Prenatal tests
The RhoGAM shot and Rh-negative blood in pregnancy: what to know
At a glance
- Who it is for
- People who are Rh negative and have not made Rh antibodies. People who are Rh positive do not need it. ACOG says to talk with your ob-gyn about whether you need it and when.
- Blood tests first
- A blood test for blood type and Rh factor, usually at the first prenatal visit. If you are Rh negative, an antibody screen shows whether your body has made Rh antibodies.
- The shot
- Rh immune globulin, often called RhoGAM, is usually given around 28 weeks of pregnancy. If the baby is Rh positive, a second dose is given within 72 hours after the birth.
- At the visit
- A shot, usually into a muscle. The RhoGAM and Rhophylac labels tell staff to watch the person for at least 20 minutes afterward.
- Results
- Ask your practice when to expect the blood type and antibody screen results.
What it is
Your blood type has a letter (A, B, AB or O) and a positive or negative sign. The sign is your Rh factor. The Rh factor is a protein on the surface of red blood cells. If your red blood cells have it, you are Rh positive. If they do not, you are Rh negative.
Most people are Rh positive. The Rh factor is inherited, which means it is passed from parent to child through genes. A baby can get it from either parent. A baby who gets it from neither parent is Rh negative.
MedlinePlus says being Rh negative does not affect your own health. In pregnancy, ACOG says problems can occur if you are Rh negative and your baby is Rh positive. That combination is called Rh incompatibility, and MedlinePlus says it develops only in that combination.
Here is how it can start. During pregnancy, your blood and your baby’s blood usually do not mix, but a small amount of the baby’s blood can reach yours. The greatest chance of this is during delivery. ACOG names other times too, such as bleeding during pregnancy or an injury to the abdomen. It says Rh antibodies can also develop after a miscarriage, an ectopic pregnancy (a pregnancy that grows outside the womb) or an abortion.
Your body can make antibodies against the baby’s Rh factor. These are called Rh antibodies. They can cross the placenta (the organ that connects you and the baby) and attack the baby’s red blood cells, which can cause a serious type of anemia in the baby (anemia means too few red blood cells) and jaundice (yellowing of the skin and eyes) in a newborn. ACOG says that in some cases a baby can die from the anemia. Rh sensitization usually does not cause problems in a first pregnancy, but it can in a later one if it is not prevented. ACOG says problems from Rh incompatibility can be prevented, and MedlinePlus calls it almost completely preventable.
ACOG says the goal is to stop antibodies from forming in the first place. That means finding out early in pregnancy, or before, whether you are Rh negative and, when it is needed, giving Rh immune globulin.
Rh immune globulin is a medicine that stops the body from making Rh antibodies if it has not already made them. It is given as a shot, and it is made from human blood plasma (the liquid part of blood) donated by people who have Rh antibodies in their blood. RhoGAM is one brand. HyperRHO, Rhophylac and WinRho are others, and each has its own FDA label.
When it happens
Your blood type and Rh factor are checked with a blood test, usually at your first prenatal visit. womenshealth.gov lists “your blood type and Rh factor” among the first-visit tests. ACOG’s Practice Bulletin 181 (August 2017, reaffirmed 2026), a guide for clinicians, says all pregnant people should have this blood test at the first visit and be screened for antibodies.
The antibody screen is a second blood test. It shows whether an Rh-negative person has made antibodies to Rh-positive blood. If you are Rh negative and your baby could be Rh positive, ACOG’s patient page says you may have it in the first trimester and again at 28 weeks. MedlinePlus says it is usually done in early pregnancy as part of routine prenatal testing, that it also looks for other, less common red blood cell antibodies that could affect a baby, and that people who are Rh positive may have it too. ACOG’s practice bulletin advises an antibody screen before the shot is given.
If you are Rh negative and have not made Rh antibodies, Rh immune globulin is usually given around 28 weeks of pregnancy. ACOG says 28 weeks. The labels word it a little differently: the RhoGAM label says 26 to 28 weeks, the HyperRHO label says about 28 weeks, the WinRho label says 28 weeks, and the Rhophylac label says week 28 to 30.
ACOG’s practice bulletin says the shot should be offered then to Rh-negative people who have not made antibodies. ACOG’s patient page says to talk with your ob-gyn about whether you need it and when you might be given it. Whether to have the shot is a decision for you and your provider.
The weeks on this page are full weeks of pregnancy: 28 weeks means 28 full weeks done. Ask your provider when your shot is planned, and when any later dose is due.
After the birth, the baby’s blood type is checked. If the baby is Rh positive, a second dose is given within 72 hours of the delivery. If the baby is Rh negative, MedlinePlus says no other treatment is needed. A new dose is needed with each pregnancy and delivery of an Rh-positive baby.
ACOG’s patient page lists other times when a dose is recommended. They include an ectopic pregnancy, amniocentesis or chorionic villus sampling (CVS, tests that take a sample from inside the womb), bleeding after 20 weeks of pregnancy, an injury to the abdomen, an attempt to turn a breech baby (a baby who would come out bottom or feet first), and a miscarriage or abortion at 12 weeks or more.
If you are less than 12 weeks pregnant at the time of a miscarriage or abortion, ACOG’s patient page says to talk with your ob-gyn about whether Rh immune globulin is right for you.
If you have bleeding, an injury to the abdomen, a procedure such as amniocentesis or CVS, or a pregnancy loss, call your provider promptly. If a dose is advised, the RhoGAM label says to give it within 72 hours of suspected or proven exposure to Rh-positive red blood cells, and ACOG’s practice bulletin says the ideal time is within 72 hours of the event.
If the dose after the birth, or after bleeding or a procedure, was missed or delayed, tell your provider right away. ACOG’s practice bulletin says the ideal time is within 72 hours, that the longer the dose is delayed the less protective it will be, and that it has been suggested a person may still get some benefit later. The HyperRHO label says that for the after-birth dose, a lesser degree of protection is afforded beyond 72 hours, but the dose may still be given.
What happens
- A simple blood test shows your blood type and Rh factor, usually at your first prenatal visit. It needs no special preparation.
- If you are Rh negative and your baby could be Rh positive, you may have an antibody screen. The sample is taken from a vein in your arm. MedlinePlus says it needs no special preparation, usually takes less than five minutes, and has very little risk, such as slight pain or bruising where the needle went in.
- If the antibody screen finds no antibodies, you may be given Rh immune globulin to stop them from forming. MedlinePlus says a negative result means no red blood cell antibodies were found.
- The shot is an injection, usually into a muscle. The RhoGAM and HyperRHO labels say it is for injection into a muscle only. The Rhophylac and WinRho labels say it can be given into a muscle or into a vein. Your provider sets the dose.
- After the shot, the RhoGAM and Rhophylac labels tell staff to watch the person for at least 20 minutes, so plan to stay for a little while. Ask the office what to expect, and tell the staff if you feel unwell.
- After the birth, the baby’s blood type is checked. If the baby is Rh positive, a second dose is given within 72 hours.
After a birth or certain events, a lab test may be used to estimate how much of the baby’s blood reached yours. A larger amount can mean more than one dose is needed.
Side effects. The RhoGAM label lists injection-site reactions as the most common: swelling, hardness, redness, and mild pain or warmth. A rash, body aches or a slight rise in temperature are possible. The HyperRHO label describes slight soreness at the injection site and a slight rise in temperature. In the two studies in pregnant women described in the Rhophylac label, the most common reactions were nausea, dizziness, headache, injection-site pain and malaise, which means feeling unwell.
Serious reactions. The RhoGAM label says severe reactions can occur, including allergic reactions. The HyperRHO label says systemic (whole-body) reactions to human immunoglobulin preparations are rare. Serious allergic reactions can happen with Rh immune globulin even in people who handled earlier doses well. The RhoGAM label says it should be given where trained staff and medicines to treat an allergic reaction are available. The RhoGAM label lists signs of an allergic reaction such as hives (including widespread hives), tightness of the chest, wheezing, low blood pressure and anaphylaxis (a severe allergic reaction). Tell the staff right away if you notice any of these signs.
Allergy history. The labels differ on who should not be given the shot because of allergy history. The RhoGAM label lists people with a known history of anaphylactic (severe allergic) or other severe whole-body reactions to human immune globulin products. The Rhophylac and WinRho labels list those people too, and also some people with IgA deficiency (too little of an antibody called IgA). The HyperRHO label lists no known contraindications (reasons not to use it), and advises caution for people who have had earlier whole-body allergic reactions to immune globulin products and for isolated IgA deficiency.
Two labels add warnings of their own. The RhoGAM label warns of a potential risk of an allergic reaction in people with IgA deficiency, and says the doctor must weigh the benefit against the potential risks. The WinRho label says people with a corn allergy should avoid it, because it contains a sugar made from corn. Tell your provider about any allergies, including any past severe reaction to a blood product or immune globulin.
Made from human plasma. Because it is made from human plasma, the RhoGAM label says it may carry a risk of transmitting infectious agents. The same label says donors are screened, viruses are removed and inactivated, and there have been no documented cases of infectious disease transmission by RhoGAM. ACOG’s practice bulletin calls the theoretical risk of viral infection “exceedingly low”.
For the baby. The labels word this differently. The RhoGAM label says the available evidence suggests it does not harm the baby or affect future pregnancies or reproduction capacity. The Rhophylac and WinRho labels say it was not shown to harm the fetus or newborn in a clinical trial. The HyperRHO label says it is not known whether it can cause fetal harm and that it should be given to a pregnant woman only if clearly needed. The RhoGAM, Rhophylac and HyperRHO labels also say animal reproduction studies have not been conducted. ACOG’s practice bulletin says the shot should be offered at 28 weeks to Rh-negative people who have not made antibodies.
Breastfeeding. After the birth, the RhoGAM label says the shot can be used during breastfeeding, and that immunoglobulins are excreted in human milk. The Rhophylac label says it has no information on whether the shot gets into human milk, and that the product is used in nursing mothers.
Vaccines after the shot. The labels say Rh immune globulin may make some live vaccines, such as measles, mumps and varicella (chickenpox) vaccines, work less well, and that these vaccines should generally be delayed afterward. The RhoGAM label says a rubella or MMR vaccine after the birth, for someone who is not immune to rubella, should not be delayed because of the shot. Ask your provider about vaccines after the shot.
These are the points the sources and labels raise. Ask your provider to go over them with you, along with your own health history.
What the shot does and does not do
What the shot does
- It stops the body from making Rh antibodies, if the body has not already made them. ACOG says this can prevent severe anemia in a baby in a future pregnancy.
- The dose around 28 weeks is aimed at any of the baby’s Rh-positive cells that may reach your blood in the last months of pregnancy, so that antibodies are not made against them.
- The dose after the birth is given because the greatest chance of the baby’s blood reaching yours comes at delivery.
- The RhoGAM and HyperRHO labels say it acts by suppressing the immune response to Rh-positive red blood cells. The RhoGAM label says the mechanism of action is unknown, and the HyperRHO label says it is not fully understood.
What it does not do
- It does not help once the body has already made Rh antibodies.
- It is not needed by people who are Rh positive. The problem comes up when the pregnant person is Rh negative and the baby is Rh positive. If your lab report says “weak D”, ask your provider what it means for you.
- It does not work in every case. ACOG’s practice bulletin says a small share of people at risk still make Rh antibodies even when the recommended steps are followed. Ask your provider what this means for you.
- It protects only the pregnancy it is given for. ACOG says each pregnancy and delivery of an Rh-positive baby needs its own dose.
- It is not given to the baby. The RhoGAM label says not to inject the newborn.
If the antibody screen finds Rh antibodies, ACOG says the baby’s well-being is checked during the pregnancy, usually with ultrasound exams. MedlinePlus says there may be more frequent tests. Ask your provider to explain what comes next.
Antibodies from an earlier dose can show up on a later antibody screen. ACOG’s practice bulletin says the provider should work out whether antibodies that are found came from an earlier dose or from the person’s own body. If it is clear they came from an earlier dose, ACOG says the person should continue to be offered the shot. The RhoGAM label says a screen made positive by the shot does not preclude further doses. Tell the staff if you have already had a dose.
The baby’s and the father’s blood type. The RhoGAM label says the shot is for Rh-negative women who have not made antibodies, unless the baby’s father or the baby is conclusively Rh negative. The HyperRHO label says it need not be given if the father can be determined to be Rh negative. MedlinePlus says that if the father is Rh positive or his blood type is not known, the pregnant person is given the injection.
If the father’s Rh type is not known, ACOG’s practice bulletin says routine Rh immune globulin in pregnancy remains the preferred option. It adds that testing the father would probably not be done by most clinicians. More generally, when the baby’s or the father’s blood type is not known, the labels treat the pregnancy as one that could be Rh incompatible.
A blood test on the pregnant person’s blood, called cell-free DNA testing, can find the baby’s Rh type before birth. ACOG’s practice bulletin (August 2017, reaffirmed 2026) says cost comparisons with routine prophylaxis have not shown a consistent benefit, and that at current costs it is not recommended for routine use at present. Ask your provider if you have questions about it.
What the partner does
- Ask the office whether partners can come to the appointment where the antibody screen or the shot is given, and go along if you can.
- The baby can get the Rh factor from either parent. The RhoGAM label says the shot is for Rh-negative women unless the baby’s father or the baby is conclusively Rh negative, so your blood type can matter. Know your own blood type, and tell the practice if it asks.
- Ask when the shot is planned and put the date in your phone. The RhoGAM and Rhophylac labels tell staff to watch the person for at least 20 minutes afterward, so keep the time after the visit free.
- Bring something to do for the wait.
- The antibody screen is a quick blood draw that needs no special preparation. It may be repeated at 28 weeks, before the shot. Ask the office how the blood tests and the shot fit into your visits.
- After the birth, the baby’s blood type is checked, and a second dose is given within 72 hours if the baby is Rh positive. Ask the practice how this is handled at the hospital or birth center where you will deliver, and write down the answer.
- If a dose comes after bleeding, a procedure or a loss, your part is to be there, to help make the call to the practice promptly and to handle the practical things, like getting there and home. Let the practice explain the details.
- If your partner has ever had a severe reaction to a blood product or to immune globulin, make sure the practice knows.
- Write your questions down before the visit. For example: Do I need the shot now or later? Which brand do you use? What do I do if I have bleeding?
- Ask when results will be shared and who will call, and put that in your phone.
- Check with your insurance plan about what it covers, and ask the practice about any cost.
Questions people ask
What is the RhoGAM shot?
RhoGAM is one brand of Rh immune globulin, a medicine given as a shot to people who are Rh negative and have not made Rh antibodies. It stops the body from making those antibodies. It is made from human blood plasma and is given to the pregnant person, not to the baby. HyperRHO, Rhophylac and WinRho are other brands.
When do you get the RhoGAM shot during pregnancy?
It is usually given around 28 weeks of pregnancy to people who are Rh negative and have not made Rh antibodies. ACOG says 28 weeks, and the RhoGAM label says 26 to 28. A second dose is given within 72 hours after the birth if the baby is Rh positive. Ask your provider when yours is planned.
What does Rh negative mean in pregnancy?
Rh negative means your red blood cells do not have the Rh factor, a protein on their surface. MedlinePlus says it does not affect your own health. In pregnancy, ACOG says problems can occur if you are Rh negative and your baby is Rh positive. Your body can then make antibodies against the baby’s blood cells. ACOG says these problems can be prevented.
Is the RhoGAM shot safe?
ACOG’s practice bulletin says to offer the shot at 28 weeks to Rh-negative people who have not made antibodies. The RhoGAM label lists injection-site reactions as most common and warns that serious allergic reactions can happen. For the baby, it says the evidence suggests no harm to the fetus. The HyperRHO label says it is not known whether it can harm the baby. Ask your provider how this applies to you.
Do I need RhoGAM if my baby is Rh positive or Rh negative?
ACOG’s practice bulletin says to offer the shot at 28 weeks to Rh-negative people who have not made antibodies. At current costs, it does not recommend routine cell-free DNA testing on the pregnant person’s blood for the baby’s Rh type before birth. After the birth, a second dose is given within 72 hours if the baby is confirmed Rh positive. MedlinePlus says no other treatment is needed if the baby is Rh negative.
Does the father’s blood type matter for RhoGAM?
It can. The baby can get the Rh factor from either parent. The RhoGAM label says the shot is for Rh-negative women unless the baby’s father or the baby is conclusively Rh negative. If the father’s Rh type is not known, ACOG’s practice bulletin says routine Rh immune globulin in pregnancy remains the preferred option. Ask your provider how this applies to you.
In the app
Sources
- The Rh Factor: How It Can Affect Your Pregnancy (opens in a new tab)ACOG · Updated September 2024; page dated October 2025
- Routine Tests During Pregnancy (opens in a new tab)ACOG · Updated April 2024; page dated January 2026
- Practice Bulletin No. 181, Prevention of Rh D Alloimmunization (abstract page) (opens in a new tab)ACOG · August 2017, reaffirmed 2026
- Practice Bulletin No. 181, Prevention of Rh D Alloimmunization (full text) (opens in a new tab)ACOG, Obstetrics & Gynecology 130(2):e57-e70 · August 2017
- Rh incompatibility (opens in a new tab)MedlinePlus (NIH, National Library of Medicine) · Page dated January 1, 2025
- Rh Incompatibility (opens in a new tab)MedlinePlus (NIH, National Library of Medicine) · Updated July 2, 2025
- Red Blood Cell Antibody Screen (opens in a new tab)MedlinePlus (NIH, National Library of Medicine) · Updated January 21, 2025
- Blood typing (opens in a new tab)MedlinePlus (NIH, National Library of Medicine) · Page dated January 29, 2026
- Prenatal care and tests (opens in a new tab)womenshealth.gov (HHS Office on Women’s Health) · Page last updated September 26, 2025
- RhoGAM Ultra-Filtered Plus (Rho(D) immune globulin human) prescribing information (opens in a new tab)Kedrion Biopharma, via NLM DailyMed · DailyMed published November 17, 2025
- HyperRHO Full Dose (Rho(D) immune globulin human) (opens in a new tab)Grifols USA, via NLM DailyMed · Revised 5/2025; DailyMed published July 17, 2025
- Rhophylac (Rho(D) immune globulin intravenous, human) (opens in a new tab)CSL Behring AG, via NLM DailyMed · DailyMed published August 13, 2025
- WinRho SDF (Rho(D) immune globulin intravenous, human) (opens in a new tab)Kamada Ltd., via NLM DailyMed · DailyMed published October 15, 2026
Sources last checked:
Medical disclaimer: General info, not medical advice. Your OB, midwife or pediatrician knows your situation; check with them. If something feels wrong, don't wait on an app. Call your provider, or 911 in an emergency. Read the full medical disclaimer